ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2112

Hip and Knee Arthroplasty In Patients With Rheumatoid Arthritis: Results From The Australian Orthopaedic Association National Joint Replacement Registry: 2003 To 2011

Andrew Lim1, Stephen Graves2, Yen Liu2, Lionel Schachna1 and Russell R. Buchanan1, 1Rheumatology, Austin Health, Melbourne, Australia, 2Australian Orthopaedic Association National Joint Replacement Registry, Adelaide, Australia

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Arthroplasty, Hip, Knee, rheumatoid arthritis (RA) and rheumatoid arthritis, treatment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Orthopedics, Low Back Pain and Rehabilitation

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Total Joint Replacement in rheumatoid arthritis (RA) patients is a marker of disease severity. Whilst the rate of total hip (THA) and total knee arthroplasties (TKA) are increasing in Australia, this may not be the case for those patients with rheumatoid arthritis. Currently, there are no published data examining the rates of hip and knee joint replacement surgery, revision rates and mortality following total joint arthroplasty in rheumatoid arthritis over time in Australia. The aim of the study was to determine if the rate of THA and TKA undertaken for RA in Australia has changed since 2003. A secondary aim was to assess the outcome of both THA and TKA undertaken for RA versus Osteoarthritis (OA) during the study period.

Methods:

The Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) collects validated data on all THA and TKA procedures throughout Australia. Registry data include patient demographics, diagnosis, prosthesis type and features, method of fixation and surgical technique. Patient specific outcomes are determined by linking the primary procedure to any subsequent revision or death. Data collection commenced in 1999 and full national data collection was achieved in mid-2002. All hospitals in Australia that perform joint replacement surgery contribute to this registry. A Chi-Square test was used to compare the distribution of RA and OA in THA and TKA. Kaplan-Meier estimates of survivorship and Cox Proportional hazards models were used to compare revision rates and mortality.

Results:

The proportion of both THA and TKA undertaken for RA decreased significantly between 2003 and 2011, THA; 1.74% vs 0.84% (chi2=71.9, p<0.0001) and TKA; 2.38% vs 1.15% (chi2=135.7, p< 0.0001).

There was no significant difference in the overall rate of revision for primary THA undertaken for RA and OA (HR=1.20, 95CI, 0.98-1.48, p=0.074) but revision rates were higher for dislocation in RA  (HR=2.36, 95CI, 1.68-3.31, p<0.001). There is a significantly higher rate of mortality in RA following THA (HR=2.03, 95CI, 1.76-2.33, p<0.001).

There was a significantly lower rate of revision for primary TKA undertaken for RA compared to OA after 9 months (9mths-2yrs: HR=0.38, 95CI, 0.25-0.58, p<0.001, 2-2.5yrs: HR=0.27, 95CI, 0.10-0.72, p=0.009 and 2.5+yrs: HR=0.67, 95CI, 0.48-0.93, p=0.016). TKA for RA has a significantly higher rate of mortality than patients with OA in TKA (HR=2.07, 95CI, 1.84-2.32, p<0.001).

Conclusion:

A reduction in the total numbers of THA and TKA in RA patients across Australia has occurred over the last 9 years.  The lesser numbers may be the result of improvements in disease control but further studies are needed to clarify.  Outcomes of both THA and TKA undertaken for RA appear different when compared to OA.


Disclosure:

A. Lim,
None;

S. Graves,
None;

Y. Liu,
None;

L. Schachna,
None;

R. R. Buchanan,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hip-and-knee-arthroplasty-in-patients-with-rheumatoid-arthritis-results-from-the-australian-orthopaedic-association-national-joint-replacement-registry-2003-to-2011/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology